ストックスクリーナーアプリを入手
96.45
1.33%
1.27
前日終値:
$95.18
開ける：
$95.06
24時間の取引高:
1.96M
Relative Volume:
0.89
時価総額：
$19.11B
収益：
$8.01B
当期純損益:
$807.20M
株価収益率:
23.87
EPS:
4.0411
ネットキャッシュフロー:
$1.13B
1週間 パフォーマンス:
+7.27%
1か月 パフォーマンス:
+9.18%
6か月 パフォーマンス:
-6.56%
1年 パフォーマンス:
-3.46%
1日の値動き範囲:
$95.06
$97.00
1週間の範囲:
$87.37
$97.22
52週間の値動き範囲:
$84.59
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
名前
Zimmer Biomet Holdings Inc
セクター
電話
(574) 267-6131
住所
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
96.45 | 18.86B | 8.01B | 807.20M | 1.13B | 4.0411 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-09 | ダウングレード | Goldman | Neutral → Sell |
| 2026-01-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-12-16 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-07-15 | アップグレード | Roth Capital | Neutral → Buy |
| 2024-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 開始されました | Wolfe Research | Peer Perform |
| 2024-07-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-21 | アップグレード | Argus | Hold → Buy |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 開始されました | ROTH MKM | Neutral |
| 2023-08-28 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-05-03 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-04-11 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-03-31 | アップグレード | Jefferies | Underperform → Hold |
| 2023-03-29 | 開始されました | UBS | Sell |
| 2023-03-10 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-11-23 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Underweight |
| 2022-10-12 | 開始されました | Jefferies | Underperform |
| 2022-05-27 | ダウングレード | Needham | Buy → Hold |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2022-04-01 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Underperform |
| 2022-03-02 | ダウングレード | Loop Capital | Buy → Hold |
| 2022-02-08 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 繰り返されました | Citigroup | Buy |
| 2022-02-08 | 繰り返されました | Deutsche Bank | Hold |
| 2022-02-08 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2022-02-08 | 繰り返されました | JP Morgan | Neutral |
| 2022-02-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 繰り返されました | Stifel | Buy |
| 2022-02-08 | 繰り返されました | Truist | Buy |
| 2022-02-08 | 繰り返されました | UBS | Neutral |
| 2022-02-08 | 繰り返されました | Wells Fargo | Underweight |
| 2022-02-02 | ダウングレード | UBS | Buy → Neutral |
| 2022-01-19 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | ダウングレード | Needham | Strong Buy → Buy |
| 2021-12-07 | 開始されました | Loop Capital | Buy |
| 2021-11-23 | ダウングレード | Argus | Buy → Hold |
| 2021-09-14 | 再開されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-09 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 繰り返されました | Needham | Strong Buy |
| 2020-10-20 | 開始されました | Northland Capital | Market Perform |
| 2020-09-11 | 開始されました | Wolfe Research | Outperform |
| 2020-08-05 | 繰り返されました | Needham | Strong Buy |
| 2020-04-28 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-04-09 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 繰り返されました | Needham | Strong Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2020-01-07 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | アップグレード | BTIG Research | Neutral → Buy |
| 2019-09-18 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | アップグレード | Argus | Hold → Buy |
| 2019-07-30 | アップグレード | Barclays | Underweight → Equal Weight |
| 2019-07-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | アップグレード | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | アップグレード | Needham | Buy → Strong Buy |
すべてを表示
Zimmer Biomet Holdings Inc (ZBH) 最新ニュース
ABN Amro Investment Solutions Sells 11,020 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet stock: Is Wall Street bullish or bearish? - MSN
Why Zimmer Biomet Holdings Inc. stock is favored by hedge fundsWeekly Gains Summary & Accurate Buy Signal Notifications - mfd.ru
Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid US sales force overhaul and innovation cycle - MSN
Can Zimmer Biomet Holdings Inc. stock surprise with earnings upside2025 Valuation Update & Precise Trade Entry Recommendations - mfd.ru
Is Zimmer Biomet Holdings Inc. exposed to political riskPortfolio Growth Summary & High Return Trade Guides - mfd.ru
Why Zimmer Biomet Holdings Inc. stock could be next big winner2025 Major Catalysts & AI Powered Trade Plan Recommendations - mfd.ru
Zimmer Biomet (NYSE:ZBH) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Update Report: Is Zimmer Biomet Holdings Inc stock a value trap2025 Volume Leaders & Weekly Top Stock Performers List - baoquankhu1.vn
ZBH.SW Zimmer Biomet (SIX) at CHF67.50 pre-market on volume spike: Feb 2026 outlook - Meyka
Zimmer Biomet Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Market Participants Recognise Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings - 富途牛牛
Skylands Capital LLC Sells 20,100 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Sound Shore Management Inc CT Decreases Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Johnson Investment Counsel Inc. Lowers Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Envestnet Asset Management Inc. Grows Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Expects Paragon 28 To Power Double Digit Rise In 2026 - Citeline News & Insights
Zimmer Biomet Holdings Inc (ZBH) Q4 2025 Earnings Call Highlight - GuruFocus
Zimmer Biomet (NYSE:ZBH) Beats Estimates, Lifts Russell 1000 Healthcare - Kalkine Media
Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced - Yahoo Finance
Citigroup Raises Price Target for Zimmer Biomet Holdings (ZBH) | - GuruFocus
Wells Fargo Raises Zimmer Biomet Holdings (ZBH) Price Target to $98 | ZBH Stock News - GuruFocus
Wells Fargo & Company Forecasts Strong Price Appreciation for Zimmer Biomet (NYSE:ZBH) Stock - MarketBeat
UBS Adjusts Price Target on Zimmer Biomet Holdings to $89 From $86, Maintains Sell Rating - marketscreener.com
Rothschild & Co Redburn Adjusts Zimmer Biomet PT to $115 From $125, Maintains Buy Rating - marketscreener.com
Barclays Adjusts Zimmer Biomet PT to $100 From $104, Maintains Underweight Rating - marketscreener.com
ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum - Finviz
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2025 earnings call transcript - MSN
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2025 Earnings Call Transcript - Insider Monkey
Zimmer plans US salesforce reorganization - Yahoo Finance
Zimmer Biomet (ZBH) Margin Compression And One Off Loss Test Bullish Growth Narrative - Sahm
Zimmer Biomet shares climb after fourth-quarter sales and earnings growth - AlphaStreet News
Zimmer Biomet Q4 Earnings Call Highlights - MarketBeat
Zimmer Biomet earnings beat Wall Street expectations - The Journal Gazette
Research Alert: CFRA Maintains Hold Rating On Shares Of Zimmer Biomet Holdings, Inc. - 富途牛牛
Zimmer: Q4 Earnings Snapshot - Shelton Herald
BTIG Reiterates Buy Rating on Zimmer Biomet (ZBH) with $112 PT | - GuruFocus
Zimmer Biomet (NYSE:ZBH) Earns Hold Rating from Needham & Company LLC - MarketBeat
BTIG Research Reiterates Buy Rating for Zimmer Biomet (NYSE:ZBH) - MarketBeat
Citigroup Raises Price Target on Zimmer Biomet to $98 From $94, Maintains Neutral Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Zimmer Biomet to $98 From $93 - marketscreener.com
Zimmer Biomet beats quarterly estimates on strong implant demand amid US sales overhaul - marketscreener.com
Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook - Yahoo Finance
Zimmer Biomet posts Q4 beats, sets 2026 guidance - massdevice.com
Zimmer Biomet (ZBH) Exceeds Q4 Expectations with Strong Orthoped - GuruFocus
Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $1,500 million worth of its shares. - marketscreener.com
Tranche Update on Zimmer Biomet Holdings, Inc.'s Equity Buyback Plan announced on May 29, 2024. - marketscreener.com
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript - AOL.com
Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations - Finviz
Zimmer Biomet Holdings Inc (ZBH) 財務データ
収益
当期純利益
現金流量
EPS
1.69%
0.51%
大文字化:
|
ボリューム (24 時間):